FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes

PHASE2CompletedINTERVENTIONAL
Enrollment

625

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

April 30, 2010

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Varespladib Methyl (A-002)

2 Tablets (250 mg each) once daily for at least 24 weeks in combination with Atorvastatin (80 mg tablet once a day).

Trial Locations (44)

10002

Zhytomyr city hospital #1, Zhytomyr

61002

Municipal Clinical Hospital No. 27, Kharkiv

61018

Department of Cardiology of Central Clinical Hospital, Kharkiv

61039

L.T. Malaya Institute of Therapy of AMS of Ukraine, Kharkiv

61178

Kharkiv Medical Academy of Post-Graduate Education, Kharkiv

69000

Zaporizhzhya Regional Cardiological Dispensary, Zaporizhzhya

79000

Lviv Danylo Halytsky National University, Lviv

79015

Lviv Regional State Clinical Treatment and Diagnostics Cardiology Center, Lviv

88014

Uzhgorod National University, Uzhhorod

111539

State Healthcare Intstitution of Moscow, Moscow

188300

Municipal Healthcare Institution, Gatchina

190000

St.Petersburg State Healthcare Institution, Saint Petersburg

191015

State Educational Institution for Further Professional Training, Saint Petersburg

191144

St.Petersburg State Healthcare Institution, Saint Petersburg

194044

Federal State Healthcare Institution, Saint Petersburg

195197

State Healthcare Institution, Saint Petersburg

195257

St.Petersburg State Healthcare Institution, Saint Petersburg

198205

Saint-Petersburg State Healthcare Institution, Saint Petersburg

199106

St.Petersburg State Healthcare Institution, Saint Petersburg

410012

Saratov State Medical University, Saratov

410028

Federal State Institution, Saratov

443070

State Healthcare Institution, Samara

603003

City Clinical Hospital №12, Nizhny Novgorod

614107

Municipal Healthcare Institution, Perm

620109

New Hospital Medical Union, Yekaterinburg

625026

Tyumen Cardiology Center,, Tyumen

630008

Municipal Healthcare Institution, Novosibirsk

630047

Regional State Healthcare Institution, Novosibirsk

634012

State Institution Research Cardiology Institute, Tomsk

650002

Municipal Healthcare Institution, Kemerovo

650055

Non-State Healthcare Institution, Kemerovo

660022

Krasnoyarsk Medical Academy, Krasnoyarsk

0102

Cardiological hospital of The Patriarchate of all Georgia, Tbilisi

Tbilisi State Medical University, Al. Aladashvili University Clinic, Tbilisi

0141

Cardio Reanimation Centre, Tbilisi

0144

"Cardiological Clinic Guli", Tbilisi

Tbilisi LTD Cardiology Clinic, Tbilisi

0159

Emergency Cardiology Center by acad. G. Chapidze, Tbilisi

National Center of Therapy, Tbilisi

0164

Multiprofile Clinical Hospital of Tbilisi #2, Tbilisi

0179

Diagnostic Services Clinic, Tbilisi

0186

"Limited Company ADAPTI The Clinic of Angiocardiology ADAPTI", Tbilisi

02175

Kyiv City Clinical Hospital #1, Kyiv

03680

National Scientific Center, Kyiv

Sponsors
All Listed Sponsors
lead

Anthera Pharmaceuticals

INDUSTRY

NCT00743925 - FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes | Biotech Hunter | Biotech Hunter